Pre-operative Inspiratory Muscle Strength Training in Total Joint Surgery
Launched by UNIVERSITY OF FLORIDA · May 16, 2022
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how breathing exercises before orthopedic surgery, like knee or hip replacements, can help improve breathing function after the surgery. Researchers know that many people have trouble breathing for a few days following surgery, and they want to see if strengthening the breathing muscles ahead of time can make recovery easier and faster.
To participate in this study, you need to be at least 18 years old and have a history of smoking or certain lung problems that may increase the risk of complications after surgery. If you are eligible and decide to join, you will be asked to do some specific breathing exercises before your surgery. The goal is to see if these exercises can help you breathe better and recover more quickly afterward. If you have any serious health issues related to your lungs or other conditions that may complicate your participation, you may not be able to join the trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 or older
- • History of current or previous tobacco use (including vaping containing nicotine products)
- • One or more risk factors for post operative pulmonary complications including history of current or previous tobacco use, a clinically diagnosed lung disease, shortness of breath with minimal exertion, FEV1 or FVC less than 80% than predicted or respiratory muscles strength below lower limit of normal for age and sex.
- • History of smoking related lung disease
- • Projected surgical time \> 30 minutes
- • Ability to follow instructions to complete IMT exercises
- • Ability to communicate adverse effects such as pain or fatigue or the need for assistance
- Exclusion Criteria:
- • American Society of Anesthesiologists physical status classification of 4 or greater .
- • Recent history of acute pneumonia or lower respiratory infection in the previous two weeks requiring acute corticosteroid or antibiotic medication,
- • Preoperative dependence on continuous supplemental oxygen dependence.
- • Preoperative dependence on positive pressure breathing support while awake and upright (night time CPAP permitted),
- • Diagnosis of a neurologic condition (i.e. MS, ALS, Parkinson's, stroke),
- • Participating in a pulmonary rehabilitation program
- • Severe obstructive pulmonary disease (Classification of Global Initiative for Chronic Obstructive Lung Disease (GOLD) 3 or higher, indicating FEV1\<50% predicted.
- • Patients with an infectious disease requiring isolation (i.e. COVID-19).
About University Of Florida
The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jacksonville, Florida, United States
Patients applied
Trial Officials
Barbara Smith, PhD
Principal Investigator
University of Florida, College of Public Health and Health Professions - Gainesville
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials